Novel calmodulin mutations associated with congenital arrhythmia susceptibility

Circulation: Cardiovascular Genetics

Volumn 7, Issue 4, 2014, Pages 466-474

  Makita, Naomasa ^a   Yagihara, Nobue ^c   Crotti, Lia ^c   Johnson, Christopher N ^c   Beckmann, Britt Maria ^c   Roh, Michelle S ^c   Shigemizu, Daichi ^c   Lichtner, Peter ^c   Ishikawa, Taisuke ^c   Aiba, Takeshi ^c   Homfray, Tessa ^c   Behr, Elijah R ^c   Klug, Didier ^c   Denjoy, Isabelle ^c   Mastantuono, Elisa ^c   Theisen, Daniel ^c   Tsunoda, Tatsuhiko ^c   Satake, Wataru ^c   Toda, Tatsushi ^c   Nakagawa, Hidewaki ^c   Tsuji, Yukiomi ^c   Tsuchiya, Takeshi ^c   Yamamoto, Hirokazu ^c   Miyamoto, Yoshihiro ^c   Endo, Naoto ^c   Kimura, Akinori ^c   Ozaki, Kouichi ^c   Motomura, Hideki ^c   Suda, Kenji ^c   Tanaka, Toshihiro ^c   Schwartz, Peter J ^c   Meitinger, Thomas ^c   Kääb, Stefan ^c   Guicheney, Pascale ^c   Shimizu, Wataru ^c   Bhuiyan, Zahurul A ^c   Watanabe, Hiroshi ^c   Chazin, Walter J ^c   George, Alfred L ^b   more..

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NONE

Author keywords

Calmodulin; Long QT syndrome

Indexed keywords

ADRENALIN; ATENOLOL; CALCIUM; CALMODULIN; CALMODULIN 1; CALMODULIN 2; METOPROLOL; MEXILETINE; NADOLOL; PINDOLOL; PROPRANOLOL; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALM2 PROTEIN, HUMAN; PROTEIN BINDING;

ADOLESCENT; ADULT; ARTICLE; BINDING AFFINITY; BRADYCARDIA; CALCIUM BINDING; CARBOXY TERMINAL SEQUENCE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL ARRHYTHMIA; CONGENITAL DISORDER; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DIZZINESS; DRUG SUBSTITUTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EMERGENCY WARD; EXERCISE; EXERCISE TEST; EXOME; EXTRASYSTOLE; FAINTNESS; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HEART ARREST; HEART ARRHYTHMIA; HEART ATRIUM PACING; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE BIGEMINY; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFANT DISEASE; LONG QT SYNDROME; MALE; MEDICAL HISTORY; MISSENSE MUTATION; NEUROIMAGING; NEXT GENERATION SEQUENCING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; QT PROLONGATION; SEIZURE; STEADY STATE; T WAVE; UNCONSCIOUSNESS; AMINO ACID SEQUENCE; CASE REPORT; CHEMISTRY; DNA SEQUENCE; ELECTROCARDIOGRAPHY; GENETIC PREDISPOSITION; GENETICS; HIGH THROUGHPUT SEQUENCING; INFANT; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PEDIGREE; TACHYCARDIA, VENTRICULAR;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE OF ONSET; AMINO ACID SEQUENCE; CALCIUM; CALMODULIN; CHILD; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFANT; LONG QT SYNDROME; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PEDIGREE; PROTEIN BINDING; SEQUENCE ANALYSIS, DNA; TACHYCARDIA, VENTRICULAR;

EID: 84921064355     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.113.000459     Document Type: Article

References (43)

1. Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol. 2012;5:868-877
2. Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995;92:2929-2934
3. Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, Giuli LC, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation. 2000;102:2849-2855
4. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89-95
5. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339:960-965
6. Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K, et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol. 2003;41:633-642
7. Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm. 2004;1:276-283
8. Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantù F, Towbin JA, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation. 1995;92:3381-3386
9. Vincent GM, Schwartz PJ, Denjoy I, Swan H, Bithell C, Spazzolini C, et al. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of betablocker treatment "failures". Circulation. 2009;119:215-221
10. Shimizu W, Aiba T, Antzelevitch C. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome. Curr Pharm Des. 2005;11:1561-1572
11. Schwartz PJ, Ackerman MJ. The long QT syndrome: A transatlantic clinical approach to diagnosis and therapy. Eur Heart J. 2013;34:3109-3116
12. Schwartz PJ, Ackerman MJ, George AL Jr, Wilde AA. Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol. 2013;62:169-180
13. Nyegaard M, Overgaard MT, Søndergaard MT, Vranas M, Behr ER, Hildebrandt LL, et al. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet. 2012;91:703-712
14. Crotti L, Johnson CN, Graf E, De Ferrari GM, Cuneo BF, Ovadia M, et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 2013;127:1009-1017
15. Marsman RF, Barc J, Beekman L, Alders M, Dooijes D, van den Wijngaard A, et al. A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence. J Am Coll Cardiol. 2014;63:259-266
16. George AL Jr. Molecular and genetic basis of sudden cardiac death. J Clin Invest. 2013;123:75-83
17. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754-1760
18. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al; 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078-2079
19. Fujimoto A, Nakagawa H, Hosono N, Nakano K, Abe T, Boroevich KA, et al. Whole-genome sequencing and comprehensive variant analysis of a Japanese individual using massively parallel sequencing. Nat Genet. 2010;42:931-936
20. Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet. 2012;44:760-764
21. Shigemizu D, Fujimoto A, Akiyama S, Abe T, Nakano K, Boroevich KA, et al. A practical method to detect SNVs and indels from whole genome and exome sequencing data. Sci Rep. 2013;3:2161
22. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297-1303
23. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65
24. Fu W, O'Connor TD, Jun G, Kang HM, Abecasis G, Leal SM, et al; NHLBI Exome Sequencing Project. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature. 2013;493:216-220
25. Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575-576
26. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248-249
27. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073-1081
28. Shea MA, Verhoeven AS, Pedigo S. Calcium-induced interactions of calmodulin domains revealed by quantitative thrombin footprinting of Arg37 and Arg106. Biochemistry. 1996;35:2943-2957
29. VanScyoc WS, Sorensen BR, Rusinova E, Laws WR, Ross JB, Shea MA. Calcium binding to calmodulin mutants monitored by domain-specific intrinsic phenylalanine and tyrosine fluorescence. Biophys J. 2002;83:2767-2780
30. Sorensen BR, Shea MA. Interactions between domains of apo calmodulin alter calcium binding and stability. Biochemistry. 1998;37:4244-4253
31. VanScyoc WS, Shea MA. Phenylalanine fluorescence studies of calcium binding to N-domain fragments of Paramecium calmodulin mutants show increased calcium affinity correlates with increased disorder. Protein Sci. 2001;10:1758-1768
32. Fischer R, Koller M, Flura M, Mathews S, Strehler-Page MA, Krebs J, et al. Multiple divergent mRNAs code for a single human calmodulin. J Biol Chem. 1988;263:17055-17062
33. Chattopadhyaya R, Meador WE, Means AR, Quiocho FA. Calmodulin structure refined at 1.7 A resolution. J Mol Biol. 1992;228:1177-1192
34. Bunick CG, Nelson MR, Mangahas S, Hunter MJ, Sheehan JH, Mizoue LS, et al. Designing sequence to control protein function in an EF-hand protein. J Am Chem Soc. 2004;126:5990-5998
35. Wu X, Reid RE. Conservative D133E mutation of calmodulin site IV drastically alters calcium binding and phosphodiesterase regulation. Biochemistry. 1997;36:3608-3616
36. Strynadka NC, James MN. Crystal structures of the helix-loop-helix calcium-binding proteins. Annu Rev Biochem. 1989;58:951-998
37. 2+ release channel (ryanodine receptor). J Biol Chem. 2003;278:23480-23486
38. 2+ channels and promote proarrhythmic behavior in ventricular myocytes. J Molec Cell Cardiol. 2014;74:115-124
39. 2+ regulation by distinct mechanisms. J Am Heart Assoc. 2014;23:e000996
40. Hwang HS, Nitu FR, Yang Y, Walweel K, Pereira L, Johnson CN, et al. Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants. Circ Res. 2014;114:1114-1124
41. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, et al. Cav1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119:19-31
42. 2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2009;104:201-209, 12p following 209
43. 2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2006;116:2510-2520.